Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection.
about
Purification and biochemical characterization of some of the properties of recombinant human kynureninaseCrystal structure of human kynurenine aminotransferase IComparative inhibition by substrate analogues 3-methoxy- and 3-hydroxydesaminokynurenine and an improved 3 step purification of recombinant human kynureninasePharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical CorrelatesCytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaiseIndoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampusBrain extracellular matrix retains connectivity in neuronal networksIsolation, characterization, and functional expression of kynurenine aminotransferase cDNA from the yellow fever mosquito, Aedes aegypti(1).Cysteine and keto acids modulate mosquito kynurenine aminotransferase catalyzed kynurenic acid production.Tryptophan metabolites and brain disorders.Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection.Inflammatory cytokine-associated depressionThe involvement of neuroinflammation and kynurenine pathway in Parkinson's disease.Ischemic preconditioning protects neurons from damage and maintains the immunoreactivity of kynurenic acid in the gerbil hippocampal CA1 region following transient cerebral ischemia.Prolongation of levodopa responses by glycineB antagonists in parkinsonian primatesThe tryptophan oxidation pathway in mosquitoes with emphasis on xanthurenic acid biosynthesisInflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications.Endogenous neuroprotection in chronic neurodegenerative disorders: with particular regard to the kynurenines.Kynurenines in Parkinson's disease: therapeutic perspectives.Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson's disease.The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.Small molecule inhibitors in the treatment of cerebral ischemia.The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important.Effects of Kynurenine Pathway Inhibition on NAD Metabolism and Cell Viability in Human Primary Astrocytes and Neurons.Inhibitors of the kynurenine pathway as neurotherapeutics: a patent review (2012-2015).The Role of Dopamine in Inflammation-Associated Depression: Mechanisms and Therapeutic Implications.Lead discovery for human kynurenine 3-monooxygenase by high-throughput RapidFire mass spectrometry.Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin DamageQuinolinic acid: neurotoxin or oxidative stress modulator?The Genetic Link between Parkinson's Disease and the Kynurenine Pathway Is Still Missing.Role of kynurenines in the neurotoxic actions of kainic acid.A sensitive and reliable method for the detection of lipid peroxidation in biological tissues.Presynaptic kynurenate-sensitive receptors inhibit glutamate release.Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures.A metabolomic approach to ionotropic glutamate receptor subtype function: a nuclear magnetic resonance in vitro investigation.In vivo uptake and metabolism of alpha-[11C]methyl-L-tryptophan in human brain tumors.Kynurenine pathway metabolism in human blood-brain-barrier cells: implications for immune tolerance and neurotoxicity.Imaging the role of inflammation in mood and anxiety-related disorders.
P2860
Q24296383-F4652CF5-00EB-4E1C-BAD2-A8B829BD5491Q24303814-C69DF79A-E91F-4C98-BC9F-C741BC436963Q24805287-38A52AED-975E-43EC-B7FB-32B7B5CC9DF3Q26852311-01DC2664-4DC5-4C33-816B-AF0D68A7F5EEQ27001628-B9C5EE39-8AE6-4C4B-A4FA-F860256166BFQ28260918-35720727-0CF6-46F0-BDF4-72FAE0B331CAQ30666109-51BEC41D-6FAC-40F4-8D6A-5841ECEAE3B4Q31096121-17C203D7-38D5-4997-95F7-2A8923FDFD1EQ33794315-639924D4-53EE-4C9C-A4D0-38810827A5EFQ34225314-7CBD6FA8-DA5D-4AC3-B556-6D94282508B7Q34247391-E20FEEE4-7737-4DF2-849D-E14591D23AC8Q34825010-9FDFAFA3-D6FA-4F23-B237-A8A16F77BFDCQ35029070-03A0C4DA-80D1-4970-BC8E-A0DEB5C42A2CQ35609928-9A32CF0C-804B-4830-92A8-1F05C5D69A34Q35885612-7AC2E305-E42B-44D1-8586-11E2ECD2CBF7Q36637156-B7EFA868-4088-4326-B70F-6B21A78750BEQ37089253-2FE88E6A-52FF-4D7B-9B29-A33725917A66Q37580731-F21E65D4-99CB-46C2-9307-1CB2ECEECC5DQ37920750-D5906435-AC9A-415F-B980-F7970311B03FQ38063779-2ADC391F-6986-4EA8-808B-8FE0802E16B5Q38171958-0398D9A0-D958-4AE9-9092-64652EA13D7DQ38184644-D5E41806-925E-4288-85DC-4CEB82FBF54BQ38322773-218D3803-025D-4F07-B40C-E5B094768F16Q38364549-4B1F6715-FCFC-4548-B75A-081E9A1E8A92Q38728529-18DE7F35-EA6B-427A-95CF-E32843141583Q38832886-ED25B6E0-1745-455F-8F89-CBD1FF908DA2Q38844378-DA3C087C-1705-4B0F-A234-EDFCC7EE8994Q39037996-F334A3EB-C718-41A7-8089-EAA623BB4D6FQ42037158-E895A770-C3E2-4DA6-A8F9-0CC8C515F269Q42836122-BACBDCC9-694B-43C2-8EEF-8FE10D82F100Q43170816-D1739EE3-C9A8-4B46-B6A4-6B9780C598C1Q43263753-E45F885E-CAAB-4E0C-B3B0-0929A2C0650EQ43556022-711963B8-D686-459F-9CF6-46CF56234813Q43650974-38B22320-3AEA-4CA1-99F8-B84BEAC7FD12Q43718624-2D2BF0B3-67A0-4D59-AEBE-FC1BF84E314DQ44158595-2280A06E-CC8E-42A7-B303-4BCB8D0D316AQ46366680-49F6BD21-B63E-4782-8FED-4186505AA374Q46634149-6DDF733C-2A97-4C87-B240-BD6AFB95A98DQ46790380-80D13A99-007D-4C6C-8288-1693A06B203DQ47305318-DDB4BC4E-47DD-41A2-B8FE-57008A688943
P2860
Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Development and therapeutic po ...... rivatives for neuroprotection.
@ast
Development and therapeutic po ...... rivatives for neuroprotection.
@en
type
label
Development and therapeutic po ...... rivatives for neuroprotection.
@ast
Development and therapeutic po ...... rivatives for neuroprotection.
@en
prefLabel
Development and therapeutic po ...... rivatives for neuroprotection.
@ast
Development and therapeutic po ...... rivatives for neuroprotection.
@en
P1476
Development and therapeutic po ...... rivatives for neuroprotection.
@en
P304
P356
10.1016/S0165-6147(00)01451-6
P577
2000-04-01T00:00:00Z